Should all patients with immune‐mediated thrombotic...

  • Main
  • 2020 / 11
  • Should all patients with immune‐mediated thrombotic...

Should all patients with immune‐mediated thrombotic thrombocytopenic purpura receive caplacizumab?

Picod, Adrien, Veyradier, Agnès, Coppo, Paul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Thrombosis and Haemostasis
DOI:
10.1111/jth.15194
Date:
November, 2020
File:
PDF, 10.75 MB
2020
Conversion to is in progress
Conversion to is failed